Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib missed the mark in two phase 3 trials, spelling the end of the programme ...

Phase transitions and critical phenomena articles from across Nature Portfolio Phase transitions and critical phenomena are the changes of a system from one regime or state to another exhibiting ...